🔎 Trials Near Me

Hem › Akut bifentypisk leukemi › Texas › Dallas

Kliniska studier för Akut bifentypisk leukemi i Dallas, TX

6 studier för Akut bifentypisk leukemi söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RekryterarFas 1
  • UT Southwestern/Simmons Cancer Center, Dallas
Ålder 1 till 30 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06177067

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RekryterarFas 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Ålder 12 till 95 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekryterarFas 1
  • University of Texas, Southwestern, Dallas
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770

Akut bifentypisk leukemi-studier i andra städer

Andra studier i Dallas

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.